# HomeChoice Partners dba BioScript Infusion Services – FDA Inspection, Aug 17, 2018

Source: https://www.keypedia.com/records/fda_inspections/homechoice-partners-dba-bioscript-infusion-services/b167f834-d345-4fa2-8d54-b63f004a7e30
Source feed: FDA_Inspections

> FDA inspection 1063039 of HomeChoice Partners dba BioScript Infusion Services, August 17, 2018. Classification: Official Action Indicated (OAI). 2 citations under 21 CFR part 211. Form 483 issued. 1 other FDA inspection on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1063039
- Company Name: HomeChoice Partners dba BioScript Infusion Services
- Inspection Date: 2018-08-17
- Classification: Official Action Indicated (OAI)
- Classification Code: OAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 2

## Related Documents

- FDA Inspection 1149010 - 2021-08-09

## Related Officers

- [Johnetta F. Walters](https://www.keypedia.com/people/johnetta-f-walters/61bdf49d-888c-4a02-976f-5cb00aff0fa9)
- [FDA Associated Person](https://www.keypedia.com/people/tamara-j-henderson/9ccc2ac9-9d39-4bd6-8c6e-b9bae9e82554)

Company: https://www.keypedia.com/companies/homechoice-partners-dba-bioscript-infusion-services/2033b1d3-4a0c-4ca0-ace7-71940400400c

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
